Abstract：Objective To compare the positional and volumetric differences of planning target volumes (PTVs) based on fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET-CT) and four-dimensional CT (4DCT) for the primary tumor of non-small cell lung cancer (NSCLC). Methods Fifteen patients with NSCLC sequentially underwent three-dimensional CT(3DCT), 4DCT, and FDG PET-CT scans of the thorax. IGTV10 was defined on 10 respiratory phases of 4DCT images;IGTVPET was defined on PET-CT images using a fixed threshold of 15% of the maximum standard uptake values. PTV4D and PTVPET were obtained by adding a 10 mm margin around IGTV10 and IGTVPET. The differences in volume, position, and degree of inclusion (DI) between PTVPET and PTV4D were evaluated. Results There was no significant difference in centroid position between PTVPET and PTV4D (P=0.589, 0.147, and 0.096). There was no significant difference in volume between PTVPET and PTV4D (P=0.156);however, PET-CT resulted in an>20% change in PTV in 5 of 15 patients, the PTVPET volume increased (average 30%) in 10 patients, and the PTVPET volume decreased (average 11%) in 5 patients. The mean DI of PTV4D in PTVPET was 85%, and 7%-46% of PTVPET was not included within the PTV4D. The DI between PTV4D and PTVPET showed no significant correlation with the 3D motion vector (P=0.134 and 0.405). Conclusions Although there are no significant differences in centroid position and volume between PTVPET and PTV4D for the primary tumor of NSCLC, the spatial mismatch between them is apparent and the mismatch shows no correlation with tumor displacement.
Duan Yili,Li Jianbin,Zhang Yingjie et al. Comparison of PTV based on FDG PET-CT versus 4DCT in non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2015, 24(1): 42-45.
[1] Underberg RWM, Lagerwaard FJ, Slotman BJ, et al. Benefit of respiration-gated stereotactic radiotherapy for stage Ⅰ lung cancer:an analysis of 4DCT datasets[J]. Int J Radiat Oncol Biol Phys,2005,62(2):554-560.DOI:10.1016/j.ijrobp.2005.01.032. [2] Rietzel E, Liu AK, Doppke KP, et al. Design of 4D treatment planning target volumes[J].Int J Radiat Oncol Biol Phys,2006,66(1):287-295.DOI:10.1016/j.ijrobp.2006.05.024 [3] Erdi YE, Rosenzweig K, Erdi AK, et al. Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET)[J].Radiother Oncol,2002,62(1):51-60. [4] Mah K, Caldwell CB, Ung YC, et al. The impact of (18) FDG PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma:a prospective study[J]. Int J Radiat Oncol Biol Phys,2002,52(2):339-350. [5] Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2004,59(1):78-86.DOI:10.1016/j.ijrobp.2003.10.044. [6] Caldwell CB, Mah K, Skinner M, et al. Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET[J]. Int J Radiat Oncol Biol Phys,2003,55(5):1381-1393.DOI:10.1016/S0360-3016(02)04609-6. [7] Hof H, Rhern B, Haering P, et al. 4D-CT-based target volume definition in stereotactic radiotherapy of lung tumors:comparison with a conventional technique using individual margins[J].Radiother Oncol,2009,93(3):419-423.DOI:10.1016/j.radonc.2009.08.040. [8] Nawara C, Rendl G, Wurstbauer K, et al. The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy[J]. Q J Nucl Med Mol Imaging,2012,56(2):191-201. [9] Biehl KJ, Kong FM, Dehdashti F, et al. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer:is a single standardized uptake value threshold approach appropriate?[J]. J Nucl Med,2006,47(11):1808-1812. [10] Lee JA. Segmentation of positron emission tomography images:some recommendations for target delineation in radiation oncology[J]. Radiother Oncol,2010,96(3):302-307.DOI:10.1016/j.radonc.2010.07.003. [11] Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes:a survey of image segmentation techniques[J].Eur J Nucl Med Mol Imaging,2010,37(11):2165-2187.DOI:10.1007/s00259-010-1423-3. [12] Vansteenkiste JF. Nodules, CT-scans and PET-scans:a good partnership[J]. Lung Cancer,2004,45(1):29-30.DOI:10.1016/j.lungcan.2004.02.012. [13] Senan S1, De Ruysscher D. Critical review of PET-CT for radiotherapy planning in lung cancer[J].Crit Rev Oncol Hematol,2005,56(3):345-351.DOI:10.1016/j.critrevonc.2005.05.001. [14] Persson GF, Nygaard DE, Brink C, et al. Deviations in delineated GTV caused by artefacts in 4DCT[J]. Radiother Oncol,2010,96(1):61-66.DOI:10.1016/j.radonc.2010.04.019. [15] Vinod SK, Kumar S, Holloway LC, et al. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer[J]. J Med Imaging Radiat Oncol,2010,54(2):152-160.DOI:10.1111/j.1754-9485.2010.02155.x. [16] Grills IS, Yan D, Black QC, et al. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys,2007,67(3):709-719.DOI:10.1016/j.ijrobp.2006.09.046. [17] Vojtíek R, Muík J, Slampa P, et al. The impact of PET/CT scanning on the size of target volumes, radiation exposure of organs at risk, TCP and NTCP, in the radiotherapy planning of non-small cell lung cancer[J]. Rep Pract Oncol Radiother,2013,19(3):182-190.DOI:10.1016/j.rpor.2013.09.006.
2015, Vol. 24 
